| LOCATION | TITLE | category | |
|---|---|---|---|
| Sonoma Eye 2024 | Shah, et al – Anatomical Subtype Stratification for Evaluating the Safety and Efficacy of CLS-TA in Noninfectious Uveitis-Related Macular Edema: Insights from a Post-hoc Analysis of PEACHTREE | VIEW | Uveitic Macular Edema |
| Macula Society 2024 | Singer, et al - Durability with suprachoroidal injection of triamcinolone acetonide injectable suspension for uveitic macular edema and use of rescue therapy in clinical practice | VIEW | Uveitic Macular Edema |
| Ocular Immunology and Inflammation | Shah, et al – Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial | VIEW | Uveitic Macular Edema |
| AAO 2023 | Singer et al - Experience With Triamcinolone Acetonide Suprachoroidal Injection for Uveitic Macular Edema: A Physician Survey | VIEW | Uveitic Macular Edema |
| AAO 2023 | Khurana - Safety and Tolerability of Suprachoroidal Injection of CLS-AX (axitinib injectable suspension) in nAMD Patients in a Phase 1/2a Study, OASIS | VIEW | CLS-AX (axitinib injectable suspension) |
| MDPI | Wu, et al - Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery | VIEW | Suprachorodial Space and Microinjector |
| Experimental & Molecular Medicine | Choi, et al - Genome Editing in the Treatment of Ocular Diseases | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2023 | Khurana - Safety and Tolerability of Suprachoroidal Injection of CLS-AX in Neovascular AMD Patients With Persistent Activity After Anti-VEGF Therapy | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2023 | Marcus et al – Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX in Neovascular AMD Patients with Persistent Activity Following Anti-VEGF Therapy | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2023 | Kansara et al – Suprachoroidal delivery of CLS-301, a potent small molecule integrin antagonist, offers multi-month durability and high bioavailability in the chorioretina | VIEW | Preclinical Research |
| ARVO 2023 | Chang et al - Early Adoption of Triamcinolone Acetonide Suprachoroidal Injection for Uveitic Macular Edema: A Physician Survey | VIEW | Uveitic Macular Edema |
| Macula Society 2023 | Kuppermann - Safety and Tolerability Study of Suprachoroidal Injections of CLS-AX in Neovascular AMD Patients with Persistent Activity Following Anti-VEGF Therapy: OASIS Phase 1/2a Clinical Trial 6-Month Extension Study Results | VIEW | CLS-AX (axitinib injectable suspension) |
| Angiogenesis 2023 | Barakat – Suprachoroidal Therapy for Neovascular AMD | VIEW | CLS-AX (axitinib injectable suspension) |
| Retinal Physician | Suprachoroidal Drug Delivery Technology | VIEW | Suprachorodial Space and Microinjector |
| American Journal of Ophthalmology | Ciulla, et al - Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema | VIEW | Uveitic Macular Edema |
| Clinical & Experimental Ophthalmology | Singer, et al - Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular edema: A post hoc analysis of PEACHTREE | VIEW | Uveitic Macular Edema |
| Journal of Ocular Pharmacology and Therapeutics | Muya, et al - Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina | VIEW | Uveitic Macular Edema |
| Angiogenesis 2022 | Ciulla, Thomas A – The Suprachoroidal Space and Suprachoroidal Delivery for Clinicians | VIEW | Suprachorodial Space and Microinjector |
| Ocular Immunology & Inflammation | Merrill et al - Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial | VIEW | Uveitic Macular Edema |
| AAO 2021 | Grewal et al - OCT Anatomic & Temporal Biomarkers in Uveitic Macular Edema | VIEW | Uveitic Macular Edema |
| AAO 2021 | Henry et al - Post-Hoc Analysis of Suprachoroidal CLS-TA vs. Rescue Therapies in Macular Edema associated with Noninfectious Uveitis | VIEW | Uveitic Macular Edema |
| AAO 2021 | Reddy et al - Uveitic Macular Edema: Visual Function and Ocular Anatomy by Severity of Vision Loss | VIEW | Uveitic Macular Edema |
| AUS Fall 2021 | Yeh et al - Suprachoroidal SCS-TA Safety and Efficacy in Macular Edema Associated with Uveitis: Post Hoc Analysis of Clinically Relevant Subgroups | VIEW | Uveitic Macular Edema |
| AUS Fall 2021 | Kurup et al - Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal Imaging | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2021 | Major et al - Suprachoroidal Administration of Small Molecule Suspensions: Pre-Clinical Results Correlate to Clinical Trial Outcomes | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2021 | Hu et al - Safety of the Suprachoroidal Injection Procedure Via Microinjector across Three Retinal Disorders | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2021 | Kurup et al - Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal Imaging | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2021 | Grewal et al - OCT Anatomic & Temporal Biomarkers in Uveitic Macular Edema | VIEW | Uveitic Macular Edema |
| ASRS 2021 | Yeh et al - Post Hoc Analysis of Suprachoroidal CLS-TA versus Real World Rescue Therapies for Uveitic Macular Edema: Safety and Visual Function | VIEW | Uveitic Macular Edema |
| Retina Society 2021 | Albini et al - OCT Anatomic & Temporal Biomarkers in Uveitic Macular Edema | VIEW | Uveitic Macular Edema |
| Retina Society 2021 | Marcus et al - Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal Imaging | VIEW | Suprachorodial Space and Microinjector |
| Retina Society 2021 | MacCumber et al - Safety of the Suprachoroidal Injection Procedure Utilizing SCS Microinjector® across Three Retinal Disorders | VIEW | Suprachorodial Space and Microinjector |
| Retina Society 2021 | Dayani et al - Safety and Visual Function of Suprachoroidal CLS-TA versus Real World Rescue Therapies for Macular Edema associated with Noninfectious Uveitis: A Post-hoc Analysis | VIEW | Uveitic Macular Edema |
| Retina Society 2021 | Henry et al - Visual Function and Anatomic Outcomes Stratified by Baseline Visual Acuity in Patients Undergoing Suprachoroidal Injections for Macular Edema Associated with Noninfectious Uveitis | VIEW | Uveitic Macular Edema |
| Translational Vision Science & Technology | Kansara et al - Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2021 | Sharma et al - Safety of Suprachoroidal Injection Procedure Utilizing a Microinjector Across Three Retinal Disorders | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2021 | Shah et al - Post-Hoc Analysis of Suprachoroidal Injection Experience for Non-Infectious Uveitis | VIEW | Uveitic Macular Edema |
| ARVO 2021 | Muya et al - Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edema | VIEW | Diabetic Macular Edema |
| ARVO 2021 | Kansara et al - Suprachoroidally delivered non-viral DNA nanoparticles produce hMyo7A Protein in RPE-choroid in rabbits | VIEW | Gene Therapy |
| ARVO 2021 | Ho et al - Suprachoroidal Injections Across Species via Multimodal Imaging | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2021 | Goldstein et al - Uveitic Macular Edema: OCT Anatomic and Temporal Biomarkers | VIEW | Uveitic Macular Edema |
| ARVO 2021 | Fisher et al - Ophthalmic Procedure Training During COVID-19: Virtual and In-Person Training of the Suprachoroidal Injection Procedure | VIEW | Suprachorodial Space and Microinjector |
| British Journal of Ophthalmology | Kuhrana et al - Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA) | VIEW | Uveitic Macular Edema |
| British Journal of Ophthalmology | Henry et al - Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA) | VIEW | Uveitic Macular Edema |
| Multidisciplinary Digital Publishing Institute | Ciulla et al - Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases | VIEW | Suprachorodial Space and Microinjector |
| Angiogenesis 2021 | Video - Brown - Axitinib: A Novel TKI Delivered by Suprachoroidal Injection for AMD, Clinical trial injection procedure after (dark orange) Betadine Ophthalmic Prep | VIEW | CLS-AX (axitinib injectable suspension) |
| Angiogenesis 2021 | Presentation - Brown - Axitinib: A Novel TKI Delivered by Suprachoroidal Injection for AMD | VIEW | CLS-AX (axitinib injectable suspension) |
| Macula Society 2021 | MacCumber et al - Suprachoroidal Administration of Small Molecule and Nanoparticle Suspensions: Pre-Clinical Results Correlate to Clinical Trial Outcomes | VIEW | CLS-AX (axitinib injectable suspension) |
| Macula Society 2021 | Suhler et al - Post Hoc Analysis of Suprachoroidal CLS-TA versus Rescue Therapies for Uveitic Macular Edema: Safety and Visual Function | VIEW | Uveitic Macular Edema |
| Macula Society 2021 | Grewal et al - OCT Anatomic and Temporal Biomarkers in Uveitic Macular Edema | VIEW | Uveitic Macular Edema |
| Macula Society 2021 | Kurup et al - Safety of the Suprachoroidal Injection Procedure Utilizing SCS Microinjector® across Three Retinal Disorders | VIEW | Suprachorodial Space and Microinjector |
| Macula Society 2021 | Hariprasad et al - Multimodal Imaging of Suprachoroidal Injections: A Retina Surgeon’s Perspective | VIEW | Suprachorodial Space and Microinjector |
| Expert Opinion on Drug Delivery | Hancock et al - Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies | VIEW | Suprachorodial Space and Microinjector |
| Translational Vision Science & Technology | Kansara, et al - Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits | VIEW | Gene Therapy |
| AAO 2020 | Nguyen - Results from the Phase 3 PEACHTREE Clinical Trial Systemic Therapy and the Efficacy of CLS-TA: a Post-Hoc Analysis | VIEW | Uveitic Macular Edema |
| AAO 2020 | Bhisitkul et al - Suprachoroidal CLS-AX (axitinib injectable suspension) as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD) | VIEW | CLS-AX (axitinib injectable suspension) |
| Translational Vision Science & Technology | Wan et al – Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders | VIEW | Suprachorodial Space and Microinjector |
| Ophthalmology Retina | Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study | VIEW | Diabetic Macular Edema |
| Retina Society 2020 | Ip - Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis | VIEW | Retinal Vein Occlusion |
| Retina Society 2020 | Ciulla - Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: An Analysis of 12,214 Eyes | VIEW | Retinal Vein Occlusion |
| Retina Society 2020 | Merrill - Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc Analysis | VIEW | Uveitic Macular Edema |
| Retina Society 2020 | Holekamp - Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits | VIEW | Gene Therapy |
| Retina Society 2020 | Kim - Suprachoroidal Delivery of Small Molecule Suspensions and Nanoparticles | VIEW | Suprachorodial Space and Microinjector |
| Retina Society 2020 | Henry - Post hoc Analysis of Clinical Suprachoroidal Injection Experience Across Indications | VIEW | Suprachorodial Space and Microinjector |
| Retina Society 2020 | Brown - Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD) | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2020 | Fisher - Suprachoroidal Delivery with the SCS Microinjector®: Characterization of Operational Forces | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2020 | Barakat et al - Post Hoc Analysis of Clinical Suprachoroidal Injection Experience Across Indications | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2020 | Muya et al - Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2020 | Kaiser et al - Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD) | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2020 | Grewal et al - Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis | VIEW | Retinal Vein Occlusion |
| ARVO 2020 | Henry et al - Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc Analysis | VIEW | Uveitic Macular Edema |
| ASRS 2020 | Henry et al - Post Hoc Analysis of Clinical Suprachoroidal Injection Experience Across Retinal Disease Indications | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2020 | Kurup et al - Post Hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis | VIEW | Suprachorodial Space and Microinjector |
| ASRS 2020 | Nguyen - Variations in Intraocular Pressure Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA) Results from the Phase 3 PEACHTREE Clinical Trial for Uveitic Macular Edema | VIEW | Uveitic Macular Edema |
| ASRS 2020 | Reddy et al - Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc Analysis | VIEW | Uveitic Macular Edema |
| Journal of Ocular Pharmacology and Therapeutics 2020 | Viral Kinsara - Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases | VIEW | Gene Therapy |
| Ophthalmology 2020 | Yeh et al - Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3, Randomized Trial | VIEW | Uveitic Macular Edema |
| Macula Society 2020 | Kurup - Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD) | VIEW | CLS-AX (axitinib injectable suspension) |
| Macula Society 2020 | Ip - Suprachoroidal CLS-TA Plus Aflibercept Compared with Aflibercept Monotherapy for DME: Analysis of OCT Biomarkers in the Randomized Phase 2 TYBEE Trial | VIEW | Diabetic Macular Edema |
| Macula Society 2020 | Singer - IOP Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA): Results from the Phase 3 PEACHTREE Clinical Trial for Uveitis | VIEW | Uveitic Macular Edema |
| Macula Society 2020 | MacCumber - Suprachoroidal Delivery for Ocular Gene Therapy: Nonclinical Experiments Evaluating Non-Viral DNA Nanoparticles in Non-Human Primates | VIEW | Gene Therapy |
| Angiogenesis 2020 | Albini - Update on Therapeutic Suprachoroidal Injections | VIEW | Suprachorodial Space and Microinjector |
| Angiogenesis 2020 | Yeh - Front-line Local Therapies for Uveitis: From Clinical Trials to Practice | VIEW | Uveitic Macular Edema |
| RETINA 2019 | Stephen Yeh - Suprachoroidal Injection of Triamcinolone Acetonide, CLS-TA, for Macular Edema Due to Noninjectious Uveitis: A Randomized, Phase 2 Study (DOGWOOD) | VIEW | Uveitic Macular Edema |
| Experimental Eye Research 2019 | Jae Hwan Jung - Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting | VIEW | Suprachorodial Space and Microinjector |
| Drug Discovery Today 2019 | Jae Hwan Jung - Targeting drug delivery within the suprachoroidal space | VIEW | Suprachorodial Space and Microinjector |
| Acta Ophthalmologica 2019 | Habot-Wilner - Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approach | VIEW | Suprachorodial Space and Microinjector |
| AAO 2019 | Levison - A Subgroup Analysis of Subjects Diagnosed with Anterior Uveitis from the Phase 3 PEACHTREE Clinical Trial | VIEW | Uveitic Macular Edema |
| AAO 2019 | Ip - Suprachoroidal CLS-TA Plus Aflibercept Compared with Aflibercept Monotherapy for DME: Selected Secondary Results of the Randomized Phase 2 TYBEE Trial | VIEW | Diabetic Macular Edema |
| AAO 2019 | Yeh - Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA) and Intraocular Pressure: Results from the Phase 3 PEACHTREE Clinical Trial for Uveitis | VIEW | Uveitic Macular Edema |
| AAO 2019 | Kay - Suprachoroidal delivery for ocular gene therapy: nonclinical experiments evaluating non-viral DNA nanoparticles. | VIEW | Gene Therapy |
| Retina Society 2019 | Merrill – Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA) and Intraocular Pressure: Results from the Phase 3 PEACHTREE Clinical Trial for Uveitis | VIEW | Uveitic Macular Edema |
| Retina Society 2019 | Sharma - Suprachoroidal CLS-TA Maintains Efficacy Outcomes Through 48-weeks in Uveitic Macular Edema subjects: Results of the MAGNOLIA Phase 3 Extension Study | VIEW | Uveitic Macular Edema |
| EURETINA 2019 | Neumann – Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes: Results of the Phase 3 PEACHTREE Study | VIEW | Uveitic Macular Edema |
| ASRS 2019 | Ip - Suprachoroidal CLS-TA Plus Aflibercept Compared with Aflibercept Monotherapy for DME: Primary and Selected Secondary Results of the Randomized Phase 2 TYBEE Trial | VIEW | Diabetic Macular Edema |
| ASRS 2019 | Henry - Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes: Results of the Phase 3 PEACHTREE Study | VIEW | Uveitic Macular Edema |
| ASRS 2019 | Merrill - Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks: Results of the MAGNOLIA Phase 3 Extension Study | VIEW | Uveitic Macular Edema |
| ARVO 2019 | Henry - Treatment response analysis of visual acuity and central subfield retinal thickness following suprachoroidal CLS-TA | VIEW | Uveitic Macular Edema |
| ARVO 2019 | Suhler - Suprachoroidal Administration of Triamcinolone Acetonide (CLS-TA) for the treatment of Macular Edema in Noninfectious Uveitis: Pooled Results of Three Clinical Trials | VIEW | Uveitic Macular Edema |
| Macula Society 2019 | Yeh - Suprachoroidal CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveitis: Results of the Phase 3 PEACHTREE Study | VIEW | Uveitic Macular Edema |
| ASRS 2019 | Kay - Suprachoroidal administration of DNA nanoparticles transfect chorioretinal cells in primates and rabbits. Click here for video presentation | VIEW | Gene Therapy |
| Macula Society 2019 | Hariprasad - Suprachoroidally Injected CLS-TA Results in Rapid and Sustained Resolution of Macular Edema in a Majority of Patients | VIEW | Uveitic Macular Edema |
| AUS Winter 2019 | Henry - Suprachoroidal Delivery of CLS-TA for Uveitic Macular Edema: Results of the Phase 3 PEACHTREE Trial | VIEW | Uveitic Macular Edema |
| ARVO 2019 | Kansara - Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits | VIEW | Gene Therapy |
| Macula Society 2019 | Kiss - A Novel Approach to Ocular Gene Therapy: Evaluation of Suprachoroidally Administered Non-Viral DNA Nanoparticles in Rabbits | VIEW | Gene Therapy |
| AUS Winter 2019 | Merrill - Suprachoroidal CLS-TA Maintains Efficacy Outcomes Through 48-weeks in Uveitic Macular Edema subjects: Results of the MAGNOLIA Phase 3 Extension Study | VIEW | Uveitic Macular Edema |
| ASRS 2019 | Shah - Clinical Experience with the SCS Microinjector™ for Suprachoroidal Injections by Ophthalmologists | VIEW | Suprachorodial Space and Microinjector |
| Macula Society 2019 | Wykoff - Suprachoroidal CLS-TA Plus Aflibercept Compared to Aflibercept Monotherapy for DME: Results of the Randomized Phase 2 TYBEE Trial | VIEW | Diabetic Macular Edema |
| Ophthalmology Retina 2018 | Charles C. Wykoff - Suprachoroidal Triamcinolone for Diabetic Macular Edema: The HULK Trial | VIEW | Diabetic Macular Edema |
| ASRS 2018 | Yeh, S. - Suprachoroidally Injected CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveities Results of the Phase 3 PEACHTREE Study | VIEW | Uveitic Macular Edema |
| Advanced Drug Delivery Reviews 2018 | Bryce Chiang - The suprachoroidal space as a route of administration to the posterior segment of the eye | VIEW | Suprachorodial Space and Microinjector |
| American Journal of Ophthalmology 2018 | Alex S. Willoughby - Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion | VIEW | Retinal Vein Occlusion |
| Opthalmology Retina 2018 | Peter A. Campochiaro - Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study | VIEW | Retinal Vein Occlusion |
| OSLI Retina 2018 | Shaun I. R. Lampen - Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema | VIEW | Diabetic Macular Edema |
| ARVO 2018 | Taraborelli, D., Noronha, G., Yoo, J., Laird, O., Cooper, M. - A One-week Study to Evaluate Safety, Tolerability, and Retinal Cell Transfection of Non-viral DNA Nanoparticles Administered by Suprachoroidal Injection | VIEW | Gene Therapy |
| ARVO 2017 | Burke, B. - Targeted delivery of Triamcinolone Acetonide and CLS011A To the posterior ocular tissues via Suprachoroidal administration | VIEW | Uveitic Macular Edema |
| ARVO 2017 | Shah, M. - Development and clinical experience with Suprachoroidal injection of Triamcinolone acetonide (CLS-TA) as a local treatment for noninfectious uveitis | VIEW | Uveitic Macular Edema |
| AAO 2017 (RVO) | Campochiaro, P., Wykoff, C., Brown, C. - Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study | VIEW | Retinal Vein Occlusion |
| Retina Society 2017 | Hariprasad, S. - Patient Safety Data Across Clinical Trials Using Suprachoroidal Injection of Triamcinolone Acetonide | VIEW | Uveitic Macular Edema |
| 2017 (RVO) | Michael Singer, MD - Tanzanite Phase 2 Retinal vein occlusion (RVO) trial | VIEW | Retinal Vein Occlusion |
| AUS 2017 | Wang, R. - The potential for treatment of noninfectious uveitis using a suprachoroidal approach | VIEW | Uveitic Macular Edema |
| 2017 (RVO) | Wykoff C. Durability of Suprachoroidal Triamcinolone Acetonide in Combination with Aflibercept in the Management of Retinal Vein Occlusion: 9-Month Analysis of the TANZANITE Phase 2 Trial and Extension Study | VIEW | Retinal Vein Occlusion |
| 2017 | Wykoff, C., Khurana, R. - Suprachoroidal Triamcinolone Acetonide with & without Intravitreal Aflibercept for DME: Results of the 6 Month Prospective Phase 1/2 Hulk trial | VIEW | Diabetic Macular Edema |
| 2017 | Yoo, J - Characterization of the dynamics of liquid and gel spread in the Suprachoroidal space of enucleated porcine eyes | VIEW | Suprachorodial Space and Microinjector |
| TVST 2016 | Goldstein D, Do D, Noronha G, Kissner J, Srivastava S, Nguyen Q. - Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis | VIEW | Uveitic Macular Edema |
| ASRS 2016 | Yeh S. - Suprachoroidal Administration of Triamcinolone Acetonide: Results of a Phase 2 Study of Patients with Noninfectious Uveitis | VIEW | Uveitic Macular Edema |
| 2016 | Do D. - Clinical Trial Results From Patients With Macular Edema Due to Noninfectious Uveitis Treated With 4.0 mg of Triamcinolone Acetonide Using a Suprachoroidal Injection | VIEW | Uveitic Macular Edema |
| Translational Vision Science and Technology 2016 | Debra A. Goldstein - Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis | VIEW | Uveitic Macular Edema |
| Retina Society 2023 | Brown - Safety and Tolerability of CLS-AX via Suprachoroidal Injection in nAMD Patients with Persistent Activity Following Anti-VEGF Therapy | VIEW | CLS-AX (axitinib injectable suspension) |
| Clinical Ophthalmology 2016 | Ela Moisseiev - The suprachoroidal space: from potential space to a space with potential | VIEW | Suprachorodial Space and Microinjector |
| Journal of Ocular Pharmacology and Therapeutics 2016 | Samirkumar R. Patel - Targeted Drug Delivery Within the Eye Through the Suprachoroidal Space | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2018 | Fisher, N., Yoo, J., Hancock, S., Andino, R. - A Novel Technique to Characterize Key Fluid Mechanic Properties of the Suprachoroidal Injection Procedure in an In Vivo Model | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2016 | Brown D. Suprachoroidal Triamcinolone Acetonidewith Intravitreal Aflibercept For Retinal Vein Occlusion: Phase 2 Results –TANZANITE study | VIEW | Retinal Vein Occlusion |
| ARVO 2016 | Kissner J, Patel S, Prusakiewicz J, Alton D, Bikzhanova G, Geisler L, Burke B, Noronha G. Pharmacokinetics Including Ocular Distribution Characteristics of Suprachoidally Administered CLS011A in Rabbits Could be Beneficial for a Wet AMD Therapeutic Candidate | VIEW | Wet AMD |
| ASRS 2016 | Hariprasad S. - Suprachoroidal Administration of Triamcinolone Acetonide: Combined Results of Phase 1/2 and Phase 2 Clinical Studies | VIEW | Uveitic Macular Edema |
| ASRS 2016 | Kurup S. - Suprachoroidal Drug Administration | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2016 | Patel S, Kissner J, Zarnitsyn V, Farjo R, Noronha G. - Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2016 | Taraborelli D, Burke B, Noronha G. Ocular Tolerability and Toxicokinetics of Suprachoroidally Administered CLS-TA, Triamcinolone Acetonide Injectable Suspension, in Combination with Intravitreal Eylea® in Rabbits. ARVO Meeting Abstracts 2016; 296-B0329. | VIEW | Diabetic Macular Edema |
| ARVO 2016 | Zarnitsyn V, Patel S, Yoo J, Noronha G. - Characterization of Suprachoroidal Injection in Multiple Species. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2016 (wet-AMD) | Wet AMD Kissner J, Patel S, Prusakiewicz J, Alton D, Bikzhanova G, Geisler L, Burke B, Noronha G. – Pharmacokinetics Including Ocular Distribution Characteristics of Suprachoroidally Administered CLS011A in Rabbits Could be Beneficial for a Wet AMD... | VIEW | Wet AMD |
| Drug Discovery Today 2015 | Uma Do J.P. Rai - The suprachoroidal pathway: a new drug delivery route to the back of the eye | VIEW | Suprachorodial Space and Microinjector |
| ACS Nano | Yuan et al. Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy | VIEW | CLS-AX (axitinib injectable suspension) |
| ARVO 2014 | Andino RV, Allen EV, Patel SR, Edelhauser HF, Yoo JI. - Intraocular Pressure Changes Resulting from Suprachoroidal and Intravitreal Injections in Ex-Vivo Porcine Eyes. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2014 | Edelhauser HF, Verhoeven RS, Burke B, Struble CB, Patel SR. - Intraocular Distribution and Targeting of Triamcinolone Acetonide Suspension Administered into the Suprachoroidal Space. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2014 | Patel SR, Verhoeven RS, Burke B, Viaud K, Edelhauser HF. Safety and Tolerability of Drugs Within the Suprachoroidal Space in Albino Rabbits. ARVO Meeting Abstracts 2014; 4886-C0082. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2014 | Noronha G, Edelhauser HF, Patel SR, Burke B, Verhoeven RS. Safety and Toxicokinetics of Suprachoroidal Space Injections of Triamcinolone Acetonide Suspension in Albino Rabbits. ARVO Meeting Abstracts 2014; 4887-C0083. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2014 | Yoo JI, A32c03ndino RV, Zarnitsyn V, Strudthoff K, Patel SR, Edelhauser HF. - Ultrasound Biomicrocopy to Visualize Suprachoroidal Injections of Enucleated Human Eyes. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2014 | Zarnitsyn V, Patel SR, Verhoeven RS, Lawrence MS. - Characterization of Sodium Fluorescein Administered into the Suprachoroidal Space of Nonhuman Primates Using a Microneedle. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2013 (wet-AMD) | Wet AMD Morales-Canton V, Fromow-Guerra J, Longoria S, Vera R, Widmann M, Patel S, Yerxa B. – Suprachoroidal Microinjection of Bevacizumab is Well Tolerated in Human Patients | VIEW | Wet AMD |
| ARVO 2013 | Morales-Canton V, Fromow-Guerra J, Longoria S, Vera R, Widmann M, Patel S, Yerxa B. Suprachoroidal Microinjection of Bevacizumab is Well Torerated in Human Patients. ARVO Meeting Abstracts 2013;3299-A0150. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2013 | Burke B, Verhoeven R, Patel S. - Comparison of the Total Amount of Triamcinolone Acetonide Delivered Via Suprachoroidal or Intravitreal Administration. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2013 | Edelhauser H, Patel S, Meschter C, Dean R, Powell K, Verhoeven R. - Suprachoroidal Microinjection Delivers Triamcinolone Acetonide to Therapeutically-Relevant Posterior Ocular Structures and Limits Exposure in the Anterior Segment. ARVO Meeting Abstracts | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2013 | Gilger B, Abarca E, Salmon J, Patel S. - Treatment of Acute Posterior Uveitis by Injection of Triamcinolone Acetonide into the Suprachoroidal Space Using Microneedles. | VIEW | Uveitic Macular Edema |
| ARVO 2013 | Patel S, Carvalho R, Mundwiler K, Meschter C, Verhoeven R. - Evaluation of Suprachoroidal Microinjection of Triamcinolone Acetonide in a Model of Panuveitis in Albino Rabbits. | VIEW | Suprachorodial Space and Microinjector |
| Investigative Ophthalmology and Visual Science 2012 | Smirkumar R. Patel - Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the Eye | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2013 | Verhoeven R, Patel S, Viaud-Quentric K, Cacciamani F, Amar T, Yerxa B. - Suprachoroidal Microinjection of Triamcinolone Acetonide is Well Tolerated in the Albino Rabbit. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2012 | Berezovsky DE, Patel SR, Grossniklaus HE, Edelhauser HF. - Microneedle-Based Suprachoroidal Injections in Rabbits: Histological Study Using Triamcinolone Acetonide. ARVO Meeting Abstracts 2012;53:486. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2012 | Mansoor S, Patel SR, Tas C, et al. - Pharmacokinetics and Biodistribution of Bevacizumab Following Suprachoroidal Injection into the Rabbit Eye Using a Microneedle. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2012 | Patel SR, Powers E, Prausnitz MR, Edelhauser HF. - Fluid Infusion Into the Corneal Stroma Using a Microneedle. | VIEW | Suprachorodial Space and Microinjector |
| 6TCBio 2012 | Patel SR. - Microneedle Enabled Tissue Targeted Drug Delivery for the Anterior and Posterior Segment of the Eye. | VIEW | Suprachorodial Space and Microinjector |
| Multidisciplinary Ophthalmic Imaging 2011 | Gabriela S. Seiler - Effect and Distribution of Contrast Medium after Injection into the Anterior Suprachoroidal Space in Ex Vivo Eyes | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2012 | Patel SR. - Targeted Drug Delivery to the Suprachoroidal Space: A Minimally Invasive Approach to Treating Chorioretinal Diseases Using Microneedles. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2011 | Berezovsky DE, Patel SR, McCarey BE, Grossniklaus HE, Prausnitz MR, Edelhauser HF. In Vivo Evaluation of Fluorescent Microparticles Injected in the Rabbit Suprachoroidal Space Using Hollow Microneedles. ARVO Meeting Abstracts 2011;52:2058. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2011 | Kang SJ, Patel SR, Berezovsky DE, Zhang Q, Yang H, Grossniklaus HE. - Suprachoroidal Injection of Microspheres with Microcatheter in a Rabbit Model of Uveal Melanoma. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2011 | Patel SR, Bergman L, Berglin LC, et al. - Surface Area Coverage of Suprachoroidal Injections Using A Hollow Microneedle in Fresh Human Globes. | VIEW | Suprachorodial Space and Microinjector |
| AAO 2010 | Patel SR. - Targeting to the Suprachoroidal Space of the Eye Using a Hollow Microneedle. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2010 | Patel SR, Berezovsky D, McCarey BE, Nickerson JM, Edelhauser HF, Prausnitz MR. - Intraocular Pharmacokinetics of Suprachoroidal Drug Delivery Administered Using Hollow Microneedles. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2010 | Berglin LC, Bergman L, Patel SR, et al. - Tracing of Suprachoroidally Microneedle Injected Labeled Drugs and Microbeads in Human, Pig and Rabbit Tissue Using Liquid Nitrogen Snap-Freeze Thaw and Lypholization Techniques. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2008 | Patel S, Edelhauser HF, Nickerson JM, Prausnitz MR. - Suprachoroidal Drug Delivery Using Microneedles. | VIEW | Suprachorodial Space and Microinjector |
| ARVO 2007 | Prausnitz MR, Jiang J, Patel SR, et al. - Ocular Drug Delivery Using Microneedles. | VIEW | Suprachorodial Space and Microinjector |
